Easy, accurate, now!
Our vision is a world where every cancer patient receives the right therapy.
Our mission is to supply the healthcare systems with the necessary solutions to assure the best possible use of advanced cancer drugs.
What we offer
We empower healthcare providers with CE/IVD-certified solutions from the tissue handling to the data analysis step of the diagnostic process
Approved software for analyses of tumors to guide the use of targeted therapies and checkpoint inhibitor
Fully automated extraction solution without manual reagent handling
Oncodia was awarded Eurostars grand named "3D SELECT"
The consortium of VitroScan, Anapath, FHNW, Robovision, Uppsala University and Oncodia was awarded Eurostars grant for personalized ovarian cancer therapy selection in a multidisciplinary project, named “3D SELECT”
11 July 2019
Oncodia was awarded an EIT Health Head-Start grant
10 December 2018
In a ceremony at Uppsala University Innovation, Oncodia received the "Attractive Innovation Project Award"
4-5 December 2018
Oncodia attended BioFit2018, Lille, France
What our clients say
Give us a Call 1-888-499-9240 and we can set you up, or read more about our services here
Precision medicine solutions for better healthcare
Oncodia is an innovative Medical Technology company based in Uppsala, Sweden. We are committed to providing in vitro diagnostic products that consistently meet customer needs, enhance patient treatment outcomes and adhere to regulatory and statutory requirements. Oncodia provides CE/IVD software for precision cancer medicine as well as CE/IVD products for DNA/RNA isolation from diagnostic tissue specimens. Our focus is to supply clinical pathology and oncology with the right solutions for optimal molecular diagnostics of solid tumors.
Oncodia has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 876876
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 876876
Oncodia has acquired the assets of ExScale Biospecimen Solutions AB, including the rights to reagent kits and software CE marked for IVD for automated extraction